Replimune Group press release (REPL): Q2 GAAP EPS of -$0.54 beats by $0.21. – As of September 30, 2026, cash and cash equivalents were $307.8 million, as compared to cash, cash equivalents and short-term investments of $268.9 million as of fiscal year ended March 31, 2026
Replimune Group GAAP EPS of -$0.54 Beats by $0.21
Replimune Group press release (REPL): Q2 GAAP EPS of -$0.54 beats by $0.21. - As of September 30, 2026, cash and cash equivalents were $307.8 million, as compared to cash, cash equivalents and short-term investments of $268.9 million as of fiscal year ended March 31, 2026